Journal of ethnopharmacology · 2026
Tokishakuyakusan ameliorates age-related pregnancy loss by modulating endocrine, inflammatory, and placental factors in an advanced maternal age rat model.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Terawaki Kiyoshi, Harada-Nitta Shiori, Takiyama Mikina, Tsuchiya Naoko, Nahata Miwa, Fujitsuka Naoki, Tokita Yohei
Аннотация
ETHNOPHARMACOLOGICAL RELEVANCE: Tokishakuyakusan is a traditional Japanese Kampo medicine widely prescribed for gynecological disorders, including reproductive dysfunction.
AIM OF THE STUDY: Using an advanced maternal age (AMA) rat model, we investigated the effects of tokishakuyakusan on pregnancy loss and the mechanisms involved, including endocrine, inflammatory, and placentation-related factors.
MATERIALS AND METHODS: Aged (36-week-old) female Wistar-Imamichi rats served as the AMA model and were compared with young (12-13-week-old) controls. Before mating, AMA rats were fed either a diet containing 3% tokishakuyakusan or a control diet for 4 weeks. Pregnancy outcomes were assessed on gestational day 19, and plasma and placental samples were collected.
RESULTS: AMA rats showed a reduced live fetus rate, an increased post-implantation loss rate, fetal growth restriction, and reduced placental efficiency, together with lower plasma progesterone (P4) levels, elevated inflammatory cytokines and chemokines, lower placental fms-like tyrosine kinase-1 (Flt1/Flt-1) and placental growth factor (Pgf/PlGF) mRNA expression, and higher circulating soluble Flt-1 (sFlt-1). Placental Flt1 expression and circulating sFlt-1 levels correlated significantly with the post-implantation loss rate, indicating an association between impaired PlGF-Flt-1 signaling and pregnancy loss. Tokishakuyakusan increased the live-fetus rate, reduced the post-implantation loss rate, improved placental efficiency, increased plasma P4 levels, suppressed inflammatory mediators, increased placental Flt1 expression, and reduced circulating sFlt-1 levels.
CONCLUSIONS: AMA-related pregnancy loss is associated with endocrine imbalance, inflammation, and placental dysfunction. Tokishakuyakusan ameliorated these changes and may offer a therapeutic strategy for age-related pregnancy loss.
AIM OF THE STUDY: Using an advanced maternal age (AMA) rat model, we investigated the effects of tokishakuyakusan on pregnancy loss and the mechanisms involved, including endocrine, inflammatory, and placentation-related factors.
MATERIALS AND METHODS: Aged (36-week-old) female Wistar-Imamichi rats served as the AMA model and were compared with young (12-13-week-old) controls. Before mating, AMA rats were fed either a diet containing 3% tokishakuyakusan or a control diet for 4 weeks. Pregnancy outcomes were assessed on gestational day 19, and plasma and placental samples were collected.
RESULTS: AMA rats showed a reduced live fetus rate, an increased post-implantation loss rate, fetal growth restriction, and reduced placental efficiency, together with lower plasma progesterone (P4) levels, elevated inflammatory cytokines and chemokines, lower placental fms-like tyrosine kinase-1 (Flt1/Flt-1) and placental growth factor (Pgf/PlGF) mRNA expression, and higher circulating soluble Flt-1 (sFlt-1). Placental Flt1 expression and circulating sFlt-1 levels correlated significantly with the post-implantation loss rate, indicating an association between impaired PlGF-Flt-1 signaling and pregnancy loss. Tokishakuyakusan increased the live-fetus rate, reduced the post-implantation loss rate, improved placental efficiency, increased plasma P4 levels, suppressed inflammatory mediators, increased placental Flt1 expression, and reduced circulating sFlt-1 levels.
CONCLUSIONS: AMA-related pregnancy loss is associated with endocrine imbalance, inflammation, and placental dysfunction. Tokishakuyakusan ameliorated these changes and may offer a therapeutic strategy for age-related pregnancy loss.